2000-01-27T00:00:00
Money would be better spent on alternative ways of improving quality of life in people with secondary progressive multiple sclerosis than on the drug beta interferon, according to research conducted in Scotland.
With a HSJ subscription you’ll unlock:
Part of HSJ Information Ltd. 5th Floor, 10 Whitechapel High Street, London E1 8QS. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud